SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Sexual Dysfunction In Epilepsy And The Role Of Anti-Epileptic Drugs.

Yogarajah, M; Mula, M (2017) Sexual Dysfunction In Epilepsy And The Role Of Anti-Epileptic Drugs. Curr Pharm Des, 23 (37). pp. 5649-5661. ISSN 1873-4286 https://doi.org/10.2174/1381612823666171004115230
SGUL Authors: Mula, Marco

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (950kB) | Preview
[img]
Preview
Image (TIFF) (Figure 1) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (118kB) | Preview
[img]
Preview
Image (TIFF) (Figure 2) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (140kB) | Preview

Abstract

BACKGROUND: Sexual dysfunction is very common in patients with epilepsy. OBJECTIVE: We sought to review the published literature around sexual dysfunction in epilepsy, and particularly the role played by anti-convulsant drugs. METHOD: We searched all related articles on PubMed using the search terms sexual dysfunction, various AEDs and epilepsy, and restricted the search to English language articles. RESULTS: The most common manifestations of sexual dysfunction in patients with epilepsy are hyposexuality and erectile dysfunction. The cause of this dysfunction is multifactorial and overlapping, and includes changes in the levels of sex hormones, anti-convulsants, the epilepsy itself and psychosocial factors. Traditional anti-convulsants which induce the cytochrome P450 enzyme system have the highest rates of sexual dysfunction, which is primarily mediated by changes in sex hormone levels. Sexual dysfunction associated with newer anti-convulsants is likely to occur through different mechanisms. Some anti-convulsants such as oxcarbazepine and lamotrigine may improve sexual function, but can also rarely be associated with sexual dysfunction. CONCLUSION: Management of sexual dysfunction thought to be caused by anti-convulsants should include the cessation of the offending drug, and consideration of switching to alternative anti-convulsants that have been reported to improve sexual function such as oxcarbazepine, and lamotrigine.

Item Type: Article
Additional Information: The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/openurl/content.php?genre=article&doi=10.2174/1381612823666171004115230
Keywords: antiepileptic drugs, depression, epilepsy, erectile dysfunction, sexual dysfunction, side effects, Medicinal & Biomolecular Chemistry, 1115 Pharmacology And Pharmaceutical Sciences
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: Curr Pharm Des
ISSN: 1873-4286
Language: eng
Dates:
DateEvent
4 October 2017Published Online
27 September 2017Accepted
Publisher License: Publisher's own licence
PubMed ID: 28982319
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/109292
Publisher's version: https://doi.org/10.2174/1381612823666171004115230

Actions (login required)

Edit Item Edit Item